In June 2025, a delegation from Munich Clinic Bogenhausen—one of Southern Germany’s top teaching hospitals—visited China to explore clinical collaboration with Surgerii Robotics. Led by Prof. Johannes Bodner and Prof. Ayman Agha, the team engaged in hands-on training and live surgical observation with the SHURUI® single-port surgical robot at Ruijin Hospital, Shanghai.
The visit highlighted the SHURUI® system’s strengths in flexibility, multi-instrument synergy, and ultra-minimally invasive precision across general, thoracic, and urologic procedures. Experts from both countries exchanged insights on robotic surgery strategy, training models, and clinical outcomes.
This marks a key milestone in Surgerii Robotics’ international expansion. Joint plans are underway to initiate clinical trials in Germany, aiming to bring Chinese surgical innovation to European operating rooms. The collaboration exemplifies how global partnerships can advance the future of single-port robotic surgery—bridging continents through shared expertise and next-generation technology.
Important Notes
The SHURUI Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has obtained the CE marking for urologic laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general laparoscopic surgical procedures, and thoracoscopic surgical procedures. It is intended for use by trained surgeons in an operating room environment in accordance with the representative, specific procedures set forth in the User Manual.
Safety and Performance Information
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.
